Scholars Central

Conference abstractPublished 27 Aug 2018

Neuraminidase-1 and its role in multistage tumorigenesis

Authors: Myron R Szewczuk

Queens University, Canada

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Neuraminidase-1 (Neu1) has recently emerged as a central target in the sialidase-mediated regulation of tumorigenesis. Recent evidence indicates that Neu1 plays a much more profound role in human cancers than previously expected. In clinical setting its being essential that targeted therapies are to circumvent multistage tumorigenesis, which includes genetic mutations at the different growth factor receptors, tumor neovascularization, chemoresistance, immune-mediated tumorigenesis and the development of tissue invasion and metastasis. Firstly, the cell-surface molecular signaling platform will be described as controlling Neu1 sialidase activity, and discuss its relevance in cancer cell signaling. Second, the current understanding of Neu1 activity associated with cancer development will be summarized, and outline the key roles of Neu1 during various stages of tumorigenesis, including regulation of growth factor receptor signaling, control of Toll-like receptor (TLR) signaling and immune-mediated tumorigenesis, regulation of epithelial-mesenchymal transition (EMT), metastasis and acquired chemoresistance, and regulation of tumor vascularization.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Glycobiology
  • SubjectOncology & Cancer
  • BylineArticles whose byline prints “Myron R Szewczuk”